Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: January

Staff  |  Issue: January 2013  |  January 1, 2013

Rheumatology Audit Quize IV to counteract the adverse reaction. The infusion is discontinued and the patient is monitored for 30 minutes. The patient is scheduled for a follow-up visit in a week.

  1. What is a determining factor for determining the level of risk in the medical decision making for a patient with rheumatoid arthritis?
    1. Prescription drug management
    2. Drug therapy requiring intensive monitoring for toxicity
    3. One or more chronic illness with severe exacerbation, progression, or side effects to treatment
    4. All of the above
  2. •How many vital signs must be documented in the patient chart to get credit for examining the constitutional system during an examination?
    1. One
    2. Two
    3. Three
    4. Does not matter
  3. •Is this a level-five established patient visit: comprehensive history level, comprehensive exam level, and straightforward medical decision making?
    1. Yes
    2. No
  4. •There are two versions of documentation guidelines, 1995 and 1997. What is the difference between the two guidelines?
    1. History
    2. Examination
    3. Medical decision making
    4. Both A and B
  5. You should choose either the 1995 or 1997 guidelines depending on the payer’s recommendation.
    1. True
    2. False

click here for the answers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:Billing/CodingPractice Support Tagged with:CodingMedical decision makingRheumatoid arthritis

Related Articles

    Different Payer Audits Require Different Preparation & Response

    June 21, 2018

    For a provider of healthcare services, payer audits are always a possibility. Both government and private payers consistently monitor providers to prevent fraud, overpayment, and improper billing or coding procedures. Audits can be nerve-racking and intimidating, even if a provider is billing correctly. Improper billing can lead to civil and criminal sanctions. To alleviate some…

    What Rheumatologists Need to Know about Payer Audits

    March 15, 2016

    Both government and private payers continue to aggressively monitor providers to prevent and recover overpayments. This is evidenced by the fact that the number of audits conducted in recent years has increased dramatically. A negative audit finding can result in the need to repay five- or seven-figure amounts. Types of Audits Private Payer Audits Private…

    Phase 2 of HIPAA Audit Program Launches

    May 13, 2016

    With many competing priorities facing physician practices, HIPAA compliance and security is not a topic that usually makes it to the top of the list. But this is not the case with the Department of Health and Human Services’ Office for Civil Rights (OCR), because it has initiated a new phase of audits of physician…

    Self-Auditing Important for Rheumatology Practices

    March 15, 2016

    In its 2016 Work Plan, the HHS Office of Inspector General (OIG) outlined its plans for audits and evaluations of covered entities to work on creating a permanent and more structured audit program. In light of their focused effort, the Office for Civil Rights has indicated that they will concentrate on areas of high risk…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences